Trial intelligence / Profile preview

Effect of Diltiazem on Tacrolimus Exposure in Kidney Transplant Patients

TCTR20260611005Phase 2Not yet recruiting

Sponsor
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Start
Jun 2026
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tacrolimus in Kidney allograft status (RTx), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

tacrolimus
03

Conditions

Kidney allograft status (RTx)

Beyond the preview

Go deeper on TCTR20260611005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260611005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call